Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2023		988,782
Balance at the beginning of period at Oct. 31, 2023	$ (1,069)	$ 10	$ 1,505	$ (2,361)	$ (223)
Increase (Decrease) in Stockholders' Equity
Net earnings	622			622
Other comprehensive income (loss), net of taxes	(235)				(235)
Comprehensive income	387
Issuance of common stock in connection with employee stock plans and other (in shares)		8,677
Issuance of common stock in connection with employee stock plans and other	(76)		(76)
Repurchases of common stock (in shares)		(17,062)
Repurchases of common stock (Note 9)	(514)		(27)	(487)
Cash dividends	(545)			(545)
Stock-based compensation expense	177		177
Balance (in shares) at Jan. 31, 2024		980,397
Balance at the end of period at Jan. 31, 2024	(1,640)	$ 10	1,579	(2,771)	(458)
Balance (in shares) at Oct. 31, 2023		988,782
Balance at the beginning of period at Oct. 31, 2023	(1,069)	$ 10	1,505	(2,361)	(223)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,869
Other comprehensive income (loss), net of taxes	(192)
Comprehensive income	$ 1,677
Repurchases of common stock (in shares)	(37,500)
Balance (in shares) at Jul. 31, 2024		963,408
Balance at the end of period at Jul. 31, 2024	$ (1,392)	$ 10	1,742	(2,729)	(415)
Balance (in shares) at Jan. 31, 2024		980,397
Balance at the beginning of period at Jan. 31, 2024	(1,640)	$ 10	1,579	(2,771)	(458)
Increase (Decrease) in Stockholders' Equity
Net earnings	607			607
Other comprehensive income (loss), net of taxes	126				126
Comprehensive income	733
Issuance of common stock in connection with employee stock plans and other (in shares)		584
Issuance of common stock in connection with employee stock plans and other	(4)		(4)
Repurchases of common stock (in shares)		(3,474)
Repurchases of common stock (Note 9)	(99)		(6)	(93)
Stock-based compensation expense	94		94
Balance (in shares) at Apr. 30, 2024		977,507
Balance at the end of period at Apr. 30, 2024	(916)	$ 10	1,663	(2,257)	(332)
Increase (Decrease) in Stockholders' Equity
Net earnings	640			640
Other comprehensive income (loss), net of taxes	(83)				(83)
Comprehensive income	557
Issuance of common stock in connection with employee stock plans and other (in shares)		2,907
Issuance of common stock in connection with employee stock plans and other	$ 13		13
Repurchases of common stock (in shares)	(17,000)	(17,006)
Repurchases of common stock (Note 9)	$ (606)		(30)	(576)
Cash dividends	(536)			(536)
Stock-based compensation expense	96		96
Balance (in shares) at Jul. 31, 2024		963,408
Balance at the end of period at Jul. 31, 2024	$ (1,392)	$ 10	1,742	(2,729)	(415)
Balance (in shares) at Oct. 31, 2024	939,000	938,989
Balance at the beginning of period at Oct. 31, 2024	$ (1,323)	$ 9	1,778	(2,676)	(434)
Increase (Decrease) in Stockholders' Equity
Net earnings	565			565
Other comprehensive income (loss), net of taxes	230				230
Comprehensive income	795
Issuance of common stock in connection with employee stock plans and other (in shares)		8,405
Issuance of common stock in connection with employee stock plans and other	(92)		(92)
Repurchases of common stock (in shares)		(2,734)
Repurchases of common stock (Note 9)	(97)		(4)	(93)
Cash dividends	(547)			(547)
Stock-based compensation expense	192		192
Balance (in shares) at Jan. 31, 2025		944,660
Balance at the end of period at Jan. 31, 2025	$ (1,072)	$ 9	1,874	(2,751)	(204)
Balance (in shares) at Oct. 31, 2024	939,000	938,989
Balance at the beginning of period at Oct. 31, 2024	$ (1,323)	$ 9	1,778	(2,676)	(434)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,734
Other comprehensive income (loss), net of taxes	(207)
Comprehensive income	$ 1,527
Repurchases of common stock (in shares)	(11,400)
Balance (in shares) at Jul. 31, 2025	939,000	938,765
Balance at the end of period at Jul. 31, 2025	$ (901)	$ 9	2,091	(2,360)	(641)
Balance (in shares) at Jan. 31, 2025		944,660
Balance at the beginning of period at Jan. 31, 2025	(1,072)	$ 9	1,874	(2,751)	(204)
Increase (Decrease) in Stockholders' Equity
Net earnings	406			406
Other comprehensive income (loss), net of taxes	(639)				(639)
Comprehensive income	(233)
Issuance of common stock in connection with employee stock plans and other (in shares)		667
Issuance of common stock in connection with employee stock plans and other	(9)		(9)
Repurchases of common stock (in shares)		(3,118)
Repurchases of common stock (Note 9)	(103)		(6)	(97)
Cash dividends	1			1
Stock-based compensation expense	140		140
Balance (in shares) at Apr. 30, 2025		942,209
Balance at the end of period at Apr. 30, 2025	(1,276)	$ 9	1,999	(2,441)	(843)
Increase (Decrease) in Stockholders' Equity
Net earnings	763			763
Other comprehensive income (loss), net of taxes	202				202
Comprehensive income	965
Issuance of common stock in connection with employee stock plans and other (in shares)		2,057
Issuance of common stock in connection with employee stock plans and other	$ 5		5
Repurchases of common stock (in shares)	(5,500)	(5,501)
Repurchases of common stock (Note 9)	$ (152)		(13)	(139)
Cash dividends	(543)			(543)
Stock-based compensation expense	$ 100		100
Balance (in shares) at Jul. 31, 2025	939,000	938,765
Balance at the end of period at Jul. 31, 2025	$ (901)	$ 9	$ 2,091	$ (2,360)	$ (641)